OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC:

# Drug Count
0 CISPLATIN 5
1 FLUOROURACIL 4
2 FLUOROURACIL CREAM, 0.5% 4
3 LEVOTHYROXINE SODIUM 2
4 NIVOLUMAB 2
5 PACLITAXEL 2
6 PACLITAXEL (AIBUMIN-BOUND) 2
7 RIBAVIRIN 2
8 ALBUTEROL 1
9 ALBUTEROL SULFATE 1
See all common drugs associated with OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC

OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ARFORMOTEROL TARTRATE 1 0.0042
1 SENNOSIDES A AND B 1 0.0006
2 VONOPRAZAN FUMARATE 1 0.0001
3 VISMODEGIB 1 0.0001
4 EFAVIRENZ 1 0.0001
5 FELODIPINE 1 0.0001
6 LOPINAVIR AND RITONAVIR 1 0.0001
7 CISPLATIN 5 0.0001
8 FLUOROURACIL CREAM, 0.5% 4 0.0001
9 LEUCOVORIN CALCIUM 1 0.0001
See all drugs enriched for association with OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC